3,0
31 dic 2021
Ex dipendente, più di un anno
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Ye olde Dedalus had a multitude of good health based software products and was a market leader in Italy. Combined with the acquisition of what was formally CSC, (iSOft) & with their dominance of the UK market > the new Dedalus should have lots of coverage, many customers & market dominance. I wish them well. Lots of products but lacking support from Italy.
Svantaggi
My experience may be unfair as a new management team have taken over now & hopefully will not make the mistakes of the former management team. The UK management from a few years back, I can only describe as cruel to their employees. Cruel is a harsh word, but accurate